University of Adelaide
Dr.Tran received his B.S. degree in Biochemistry and Molecular Biology in 2003, from the University of California, Davis (UC Davis).In 2008, he completed his Ph.D.in Comparative Pathology from UC Davis. He served as a postdoctoral scholar at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) UC Davis Point-of-Care Technologies Center from 2009 – 2011. During this time he also completed a M.S. in Pharmacology and Toxicology. In 2011, he was recognized for his contributions to the field of clinical chemistry and was voted into the membership of National Academy of Clinical Biochemistry. In the same year, he was also accepted to the National Center for Advancing Translational Science (NCATS) funded Clinical and Translational Science Center’s (CTSC) K30 Mentored Clinical Research Training Program (MCRTP) to further his research training in burn critical care and focus on the clinical impact of accurate blood glucose monitoring system (BGMS) accuracy on tight glycemic control. This data precipitated significant changes in United States Food and Drug Administration (FDA) guidelines involving BGMS approval, and recent Centers for Medicare and Medicaid Services (CMS) requirements for glycemic monitoring in critically ill patients. Currently, Dr. Tran serves as Assistant Clinical Professor for the Clinical Chemistry and Point-of-Care Testing Sections through the Department of Pathology and Laboratory Medicine at UC Davis School of Medicine. He serves as Principal Investigator for a $1.87 million United States Army Medical Research and Material Command (USAMRMC) Sepsis Trial [multicenter, randomized, controlled trial] evaluating the clinical impact of rapid, quantitative, molecular determination of Staphylococcus aureus in burn sepsis patients. He is also a National Heart Blood and Lung Institute (NHLBI) Emergency Medicine K12 Career Award Scholar focusing on physiologically based pharmacokinetics for antimicrobial therapy in patients with sepsis.
Clinical Chemistry; Emergency Medicine. novel molecular pathogen detection methods. clinical outcomes-based research in burn,trauma.